The cytochrome bc1 oxidase of Mycobacterium tuberculosis is a potential target in the fight against tuberculosis. Here, the authors evaluate the potential of cytochrome bc1 inhibitors as partner drugs in tuberculosis treatment regimens.
- Clara Aguilar-Pérez
- Anne J. Lenaerts
- Dirk A. Lamprecht